Category: Oncology

Carmustine (Side Effects) Common side effects of carmustine include: Nausea and vomiting Fatigue Hair loss Increased risk of infection Low blood cell counts Pulmonary toxicity Seizures Skin rash

Carmustine (Administration) Carmustine is administered intravenously, usually in a hospital setting. The dosage and schedule of administration vary depending on the specific cancer being treated and the patient’s individual needs. Mechanism of action Carmustine works by damaging the DNA of cancer cells, preventing them from dividing and growing. It is an alkylating agent, which means […]

Carmustine (Off-label uses): Gliomatosis cerebri: Carmustine has been used off-label to treat gliomatosis cerebri, a rare brain tumor. Ependymoma: It has been used to treat ependymoma, a type of brain tumor.

Carmustine, also known as BCNU, is a chemotherapeutic agent used to treat various types of cancer. Indications: Brain tumors: Carmustine is used to treat primary brain tumors, such as glioblastoma, anaplastic astrocytoma, and medulloblastoma. Lymphoma: It is used to treat Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. Multiple myeloma: Carmustine is used in combination with other drugs […]

Desvenlafaxine (Mechanism of Action) Desvenlafaxine works by increasing the levels of two neurotransmitters, serotonin and norepinephrine, in the brain. These neurotransmitters play a crucial role in mood regulation and other functions. By increasing their levels, desvenlafaxine helps to improve mood, reduce symptoms of depression, and enhance overall mental well-being.

Desvenlafaxine is a medication that belongs to a class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs). It is primarily used as an antidepressant to treat major depressive disorder (MDD). Desvenlafaxine works by increasing the availability of certain neurotransmitters, specifically serotonin and norepinephrine, in the brain. This helps to regulate mood and alleviate symptoms of […]